Capivasertib+Fulvestrant vs Placebo+Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic HR+/HER2- Breast Cancer
Clinical trial NCT04305496 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04305496
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-16
- Primary completion
- 2023-05-09
- Enrollment
- 818
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.